EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Markers of Systemic Metabolic Dysfunction in Vitiligo and Their Potential Role in Disease Pathogenesis: A Narrative Review

Federica Papaccio iD, Simona Scano iD, Barbara Bellei iD

Health Science Reports · 2026-10 · 9 (10)

DOI: 10.1002/hsr2.72950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Science Reports, online erschienen am 25.09.2026. Verfasst von Federica Papaccio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research San Gallicano Dermatological Institute, IRCCS Rome Italy. Die Arbeit nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vitiligo is a chronic autoimmune disease characterized by the progressive destruction of melanocytes, resulting in depigmented skin macules. While traditionally viewed as a cutaneous disorder driven by a specific CD8 + T cell‐mediated interferon‐γ (IFN‐γ) signature, emerging research suggests that vitiligo may be a systemic condition linked to metabolic syndrome (MetS) and broader metabolic dysregulation.

Methods

This review synthesizes current experimental and clinical evidence regarding systemic metabolic alterations in vitiligo. We analyzed studies investigating disruptions in glucose utilization, lipid profile imbalances, and amino acid metabolism, alongside their mechanistic links to oxidative stress and immune activation.

Results

Evidence indicates that metabolic dysfunction, including aberrant glucose metabolism and lipid alterations, precedes or exacerbates immune mobilization. Key systemic factors such as advanced glycation end‐products (AGEs), proinflammatory adipokines and reduced protective factors (vitamins and small antioxidants) create a permissive environment for melanocyte apoptosis. Furthermore, some studies concerning metabolic profiling reveal that systemic biomarkers (e.g., homocysteine, total cholesterol, LDL/HDL ratio, and urinary metabolites) correlate with disease activity and treatment response.

Conclusions

Vitiligo involves a complex interplay between systemic metabolic shifts and cutaneous autoimmunity. Integrating metabolic profiling into clinical practice offers a transformative approach for identifying subclinical abnormalities, discovering biomarkers for early diagnosis, and developing personalized management strategies that address the disease beyond its dermatological manifestations.

Schlagwörter

Stichwörter der Autor:innen

metabolic syndromemetabolismvitiligo

Autor:innen und Institutionen

  • Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research San Gallicano Dermatological Institute, IRCCS Rome Italy.

ORCID-Profile: Federica Papaccio, Simona Scano, Barbara Bellei

Zitieren

APA

Papaccio, F., Scano, S., & Bellei, B. (2026). Markers of Systemic Metabolic Dysfunction in Vitiligo and Their Potential Role in Disease Pathogenesis: A Narrative Review. Health Science Reports, 9(10). https://doi.org/10.1002/hsr2.72950

Vancouver

Papaccio F, Scano S, Bellei B. Markers of Systemic Metabolic Dysfunction in Vitiligo and Their Potential Role in Disease Pathogenesis: A Narrative Review. Health Science Reports. 2026;9(10). doi:10.1002/hsr2.72950

BibTeX
@article{Papaccio2026,
  author = {Papaccio, Federica and Scano, Simona and Bellei, Barbara},
  title = {Markers of Systemic Metabolic Dysfunction in Vitiligo and Their Potential Role in Disease Pathogenesis: A Narrative Review},
  journal = {Health Science Reports},
  year = {2026},
  volume = {9},
  number = {10},
  doi = {10.1002/hsr2.72950}
}
Kostenlos starten →